18 F-labeled Bisphosphonate as an Alternative Candidate to the Gold Standard[18F]sodium fluoride ([18F]NaF) for PET Bone Imaging

18 F-labeled Bisphosphonate as an Alternative Candidate to the Gold Standard[18F]sodium fluoride ([18F]NaF) for PET Bone Imaging

Bone metastases are a common source of malignancy in the skeleton and occur much more often than primary bone cancer. Several works were being performed to identify early markers for bone metastasis and novel drug targets to improve patients' quality of life. As some concerns exist with the [18...

Full description

Bibliographic Details
Published in:Current Medical Imaging
Main Author: Hassan H.; Othman M.F.; Razak H.R.A.
Format: Article
Language:English
Published: Bentham Science Publishers 2021
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122772883&doi=10.2174%2f1573405617666210216091202&partnerID=40&md5=bf9bec452a05d67facebcaf9b5d81ecf
id 2-s2.0-85122772883
spelling 2-s2.0-85122772883
Hassan H.; Othman M.F.; Razak H.R.A.
18 F-labeled Bisphosphonate as an Alternative Candidate to the Gold Standard[18F]sodium fluoride ([18F]NaF) for PET Bone Imaging
2021
Current Medical Imaging
17
11
10.2174/1573405617666210216091202
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122772883&doi=10.2174%2f1573405617666210216091202&partnerID=40&md5=bf9bec452a05d67facebcaf9b5d81ecf
Bone metastases are a common source of malignancy in the skeleton and occur much more often than primary bone cancer. Several works were being performed to identify early markers for bone metastasis and novel drug targets to improve patients' quality of life. As some concerns exist with the [18F]sodiumfluoridein positron emission tomography (PET) bone imaging, there has been an increase in the number of targeted radiopharmaceutical markers for bone metastases imaging in its competitor,68Ga. Since18F properties are superior to those of68Ga, there is a distinct motivation for developing18F radiopharmaceuticals for bone metastases imaging. © 2021 Bentham Science Publishers.
Bentham Science Publishers
15734056
English
Article
author Hassan H.; Othman M.F.; Razak H.R.A.
spellingShingle Hassan H.; Othman M.F.; Razak H.R.A.
18 F-labeled Bisphosphonate as an Alternative Candidate to the Gold Standard[18F]sodium fluoride ([18F]NaF) for PET Bone Imaging
author_facet Hassan H.; Othman M.F.; Razak H.R.A.
author_sort Hassan H.; Othman M.F.; Razak H.R.A.
title 18 F-labeled Bisphosphonate as an Alternative Candidate to the Gold Standard[18F]sodium fluoride ([18F]NaF) for PET Bone Imaging
title_short 18 F-labeled Bisphosphonate as an Alternative Candidate to the Gold Standard[18F]sodium fluoride ([18F]NaF) for PET Bone Imaging
title_full 18 F-labeled Bisphosphonate as an Alternative Candidate to the Gold Standard[18F]sodium fluoride ([18F]NaF) for PET Bone Imaging
title_fullStr 18 F-labeled Bisphosphonate as an Alternative Candidate to the Gold Standard[18F]sodium fluoride ([18F]NaF) for PET Bone Imaging
title_full_unstemmed 18 F-labeled Bisphosphonate as an Alternative Candidate to the Gold Standard[18F]sodium fluoride ([18F]NaF) for PET Bone Imaging
title_sort 18 F-labeled Bisphosphonate as an Alternative Candidate to the Gold Standard[18F]sodium fluoride ([18F]NaF) for PET Bone Imaging
publishDate 2021
container_title Current Medical Imaging
container_volume 17
container_issue 11
doi_str_mv 10.2174/1573405617666210216091202
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122772883&doi=10.2174%2f1573405617666210216091202&partnerID=40&md5=bf9bec452a05d67facebcaf9b5d81ecf
description Bone metastases are a common source of malignancy in the skeleton and occur much more often than primary bone cancer. Several works were being performed to identify early markers for bone metastasis and novel drug targets to improve patients' quality of life. As some concerns exist with the [18F]sodiumfluoridein positron emission tomography (PET) bone imaging, there has been an increase in the number of targeted radiopharmaceutical markers for bone metastases imaging in its competitor,68Ga. Since18F properties are superior to those of68Ga, there is a distinct motivation for developing18F radiopharmaceuticals for bone metastases imaging. © 2021 Bentham Science Publishers.
publisher Bentham Science Publishers
issn 15734056
language English
format Article
accesstype
record_format scopus
collection Scopus
_version_ 1809678158933262336

Similar Items